当前位置： SCI文献检索 > International Journal of Rheumatic Diseases期刊下所有文献 > 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.

2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.

Abstract：

AIM:In June 2015, the Thai Rheumatism Association (TRA) approved an update of its recommendation for the use of biologic disease-modifying anti-rheumatic drugs (bDMARDs) and targeted synthetic (tsDMARD) in the treatment of rheumatoid arthritis (RA) to cover those currently available in Thailand (etanercept, infliximab, golimumab, rituximab, tocilizumab, abatacept and tofacitinib). METHOD:A search of the literature was performed between January 2000 and June 2015. Existing RA recommendations, in relation to the use of bDMARDs and tsDMARD, were identified and evaluated by the AGREE II instrument prior to their use as a 'guide' for developing this TRA recommendation. An additional literature search was performed in order to answer specific clinical questions that could not be found in existing guidelines. RESULT:Thirteen recommendations were developed. They covered the use of RA classification criteria, the aim of RA treatment, when to initiate bDMARDs/tsDMARD or taper or switch them to other medications, as well as monitoring these drugs during their use. In addition, specific issues including their use and vaccination, malignancies, pregnancy and lactation, and perioperative period also were addressed. Public hearings were performed at the annual meeting of the TRA and of the Royal College of Physicians of Thailand. The recommendations were distributed to other professional associations related to RA management, as well as government sectors associated with the reimbursement policy, prior to development of the final version. CONCLUSION:These recommendations will help Thai rheumatologists prescribe bDMARDs and tsDMARD more appropriately when treating RA patients.

journal_name

Int J Rheum Dis

journal_title

International journal of rheumatic diseases

authors

Louthrenoo W,Kasitanon N,Katchamart W,Aiewruengsurat D,Chevaisrakul P,Chiowchanwisawakit P,Dechanuwong P,Hanvivadhanakul P,Mahakkanukrauh A,Manavathongchai S,Muangchan C,Narongroeknawin P,Phumethum V,Siripaitoon B,Suesuwan A

doi

10.1111/1756-185X.13130

subject

Has Abstract

pub_date

2017-09-01 00:00:00

pages

1166-1184

issue

eissn

1756-1841

issn

1756-185X

journal_volume

pub_type

杂志文章,实务指引,评审

在线工具

2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.